Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model (2024)
- Authors:
- USP affiliated authors: BRITTO, LUIZ ROBERTO GIORGETTI DE - ICB ; ULRICH, ALEXANDER HENNING - IQ ; FERREIRA, ANA FLAVIA FERNANDES - ICB
- Unidades: ICB; IQ
- DOI: 10.1016/j.expneurol.2024.114780
- Subjects: FISIOLOGIA; DOENÇAS NEURODEGENERATIVAS; DOENÇA DE PARKINSON; MODELOS ANIMAIS DE DOENÇAS; CÉLULAS MORTAS; ASTRÓCITOS; NEURÓGLIA; CAMUNDONGOS; RATOS; TÉCNICAS ESTEREOTÁXICAS; IMUNOHISTOQUÍMICA; REAÇÃO EM CADEIA POR POLIMERASE
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Maryland Heights
- Date published: 2024
- Source:
- Título: Experimental Neurology
- ISSN: 1090-2430
- Volume/Número/Paginação/Ano: v. 377, art. 114780, 15 p., 2024
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
FERREIRA, Ana Flávia Fernandes et al. Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model. Experimental Neurology, v. 377, p. 15 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.expneurol.2024.114780. Acesso em: 27 dez. 2025. -
APA
Ferreira, A. F. F., Ulrich, H., Feng, Z. -P., Sun, H. -S., & Britto, L. R. G. de. (2024). Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model. Experimental Neurology, 377, 15 . doi:10.1016/j.expneurol.2024.114780 -
NLM
Ferreira AFF, Ulrich H, Feng Z-P, Sun H-S, Britto LRG de. Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model [Internet]. Experimental Neurology. 2024 ; 377 15 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.expneurol.2024.114780 -
Vancouver
Ferreira AFF, Ulrich H, Feng Z-P, Sun H-S, Britto LRG de. Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model [Internet]. Experimental Neurology. 2024 ; 377 15 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.expneurol.2024.114780 - Deletion of the transient receptor potential melastatin 2 gene mitigates the 6-hyydroxydopamine-induced Parkinson’s Disease–Like Pathology
- Deletion of the transient receptor potential Melastatin 2 gene mitigates the 6-hydroxydopamine-induced parkinson’s disease–like pathology
- The role of interleukin-17 in neurological disorders
- Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model
- The transient receptor potential melastatin 2: a new therapeutical target for Parkinson’s disease?
- Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson’s Disease animal model
- Mitochondrial abnormalities in neurological disorders
- Most utilized rodent models for Alzheimer’s and Parkinson’s disease: a critical review of the past 5 years
- Role of acetylcholine receptors in proliferation and differentiation of P19 embryonal carcinoma cells
- Participation of spontaneous 'CA POT. 2+'-transients and 'CA POT. 2+'-fluxes generated by purinergic and nicotinic acetylcholine receptors in neuronal differentiation of P19 embryonic carcinoma cells
Informações sobre o DOI: 10.1016/j.expneurol.2024.114780 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
